These results were consistent with previous observational studies, Ma et al. [34] found that SPEN gene mutation occurred in pancreatic cancer patients and is related to the progress of pancreatic cancer, MSX2 [35] and DLX1 are vital in advancing pancreatic cancer [36]. This evidence concerns the gene DLX1 and familial pancreatic carcinoma.